Glemser

We can’t wait for the Proventa International Clinical Operations and Clinical Trials Stratergy Meeting in just a few weeks!

We're just one month away from the Proventa International Clinical Operations & Clinical Trial Supply Chain Strategy Meeting in Boston on November 14th! Glemser is excited to be a co-host sponsor for this event and deliver the keynote presentation on automation in clinical labeling. This is a fantastic opportunity to gain insights and connect with leaders in the industry. Don’t forget to use VIP code GLEMSER2024 to secure your free pass* and join us in Boston! *To be eligible for a VIP PASS, you must be from a drug developing company that has a current and public drug pipeline or be in a full time academic position, that does not offer any paid for service or solutions.

Pharmaceutical companies are facing a crucial decision: should you outsource ePI conversions or bring the process in-house? It’s not one-size-fits-all, and factors like company size, product portfolio, and update frequency all come into play. In our latest blog, we explore the pros and cons of both options to help you determine the best path forward. Read it now ➡️ 🔗 https://lnkd.in/eq8qmc3z

🌍 Managing translations across global markets in life sciences can be costly and time-consuming. 💡 Advanced technologies like artificial intelligence and component content management systems (CCMS) offer efficient solutions to optimize translation processes by reducing reliance on third-party translation vendors— helping organizations reduce costs while ensuring compliance. Read the blog ➡️ 🔗 https://lnkd.in/eBFA_jRe

Looking for ways to improve patient safety in clinical labeling? 💊 Our blog post explores 3 key benefits of automation: increased accuracy, faster drug development, and enhanced patient empowerment. Check it out now ➡️ https://lnkd.in/evy5KQQP

Join us at the Proventa International Clinical Operations & Clinical Trial Supply Chain Strategy Meeting in Boston on November 14th! Glemser is proud to co-host and deliver the keynote presentation at this exciting event. Use VIP code GLEMSER2024 to secure your free pass*—don’t miss out! *To be eligible for a VIP PASS, you must be from a drug developing company that has a current and public drug pipeline or be in a full time academic position, that does not offer any paid for service or solutions.

Ray Glemser, PhD, our Founder and COO, returned to Lehigh University—his alma mater—as a judge at their 2024 Summer Research Expo, engaging with talented students and their innovative research projects. We're excited to see the next generation of thinkers and leaders in action! Happy 2024-25 school year everyone 🎉

📢 Breaking News: The Jordan Food and Drug Administration (JFDA) has mandated the launch of an electronic pharmaceutical leaflet system, aligning with global trends in ePI adoption. With a strict deadline of January 17, 2025, pharmaceutical companies face challenges in meeting new standards for compliance. Glemser is here to support you every step of the way. From re-registration within just five days to facilitating the patient lens and annotation, we will help you navigate this complex transition smoothly. Read the full press release to learn more and see how we can help ➡️ https://lnkd.in/eV--DYEb

Looking for a way to boost efficiency in the highly complex and time-consuming content generation process? ✅ improve content reuse ✅ increase transparency and traceability ✅ improve translations & more Read the blog for more tips on optimizing your workflows, increasing cost savings, and improving patient outcomes. ➡️ https://lnkd.in/dTupRUeg

Should pharma companies rush into AI for content authoring? Not so fast. 🏃💨 Starting slow ensures you choose the right tools, reducing errors and boosting productivity in the long run. Learn why taking your time with AI implementation can lead to faster, more accurate results ⬇️ 🔗 https://lnkd.in/evsPuZp3